Results 241 to 250 of about 80,496 (306)

Prevalence, risk factors, and perceptions of vaccination against reproductive tract infections among urban females in Delhi: a cross-sectional study. [PDF]

Front Reprod Health
Bhardwaj P, Yadav SK, Ghosh J, Kant R, Mangla AG, Muralidhar S, Saluja D, Sikora AE, Taneja J.   +8 more
europepmc   +1 more source

Pharmacy‐Based Immunization Delivery: A Comprehensive History and Current Challenges

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 6, June 2026.
ABSTRACT Pharmacists and their teams have a long history of involvement with vaccines. This paper describes the contributions of pharmacy‐based immunization delivery in the United States from the 1800's to date. Early activities centered around storage and distribution of antitoxins and vaccines. From the 1950s through the early 1990s, pharmacists were
Jean‐Venable R. Goode, Mitchel C. Rothholz, Stephan L. Foster, Erica R. Brody, John D. Gräbenstein   +4 more
wiley   +1 more source

Timeliness of routine vaccination among 24-35 months children in Urban Gambia. [PDF]

PLoS One
Kijera B, Sowe A, Bobb M, Jarjusey S, Manjang LF, Sillah S, Wariri O.   +6 more
europepmc   +1 more source

Media‐dependent performance of rabies virus‐like particle production under low oxygen tension in baculovirus‐infected Sf9 cells

Journal of Chemical Technology &Biotechnology, Volume 101, Issue 6, Page 1273-1282, June 2026.
Abstract BACKGROUND Rabies continues to pose a major public health threat, causing approximately 59 000 deaths each year, especially in regions with limited resources where high costs restrict vaccine access. Safer and scalable vaccine platforms, such as virus‐like particles, are promising alternatives, but their production is highly sensitive to ...
Júlia Públio Rabello, Milena Miyu Teruya, Fernanda Angela Correia Barrence, Thaissa Consoni Bernardino, Jaci Leme, Luis Giovani de Oliveira Guardalini, Noemi Nosomi Taniwaki, Soraia Attie Calil Jorge, Eutimio Gustavo Fernández Núñez   +8 more
wiley   +1 more source

Immune Response and Modeled Duration of Protection Following a Single 60 μg Hepatitis B Vaccine Booster in Susceptible Chinese University Students. [PDF]

Vaccines (Basel)
Luo X, Zhou W, Zhou S, Song F, Geng S, Xu H, Cheng Y, Ren M, Dong Y, Lin L, Mao L, Wang B, Chai Y, Miao P, Ma S, Tang J.   +15 more
europepmc   +1 more source

COVID-19 vaccine immunogenicity in Mongolian adults with and without chronic hepatitis. [PDF]

BMC Infect Dis
Callier V, Jargalsaikhan G, Batkhuu M, Ridzon R, Hunsberger S, Sereti I, Shaw-Saliba K, Weyers S, Francis A, Dashdorj N.   +9 more
europepmc   +1 more source

Engineered virus-hunter vaccine overcomes HBV immune tolerance. [PDF]

Gut
Chen X, Liu X, Xu T, Wang Y, Wang P, Liu H, Jiang Y, Qin X, Zhang L, Xiong Y, Ding J, Chen Y, Chen F, Ning W, Zeng H, Yang S, Xu L, Zhang T, Yuan Q, Liu C, Luo W, Xia N.   +21 more
europepmc   +1 more source

Lipid Nanoparticle-Encapsulated PolyI:C as an Adjuvant Enhances Both Humoral and Cellular Immune Responses to the Hepatitis B Vaccine. [PDF]

Vaccines (Basel)
Zhao Z, Wang B, Wang H, Zhang Q, Liang Y, Liu Y.   +5 more
europepmc   +1 more source

Beyond Awareness: The Critical Need for Actionable Strategies to Bridge the Knowledge‐Practice Gap in Hepatitis B Prevention

Health Science Reports, Volume 9, Issue 6, June 2026.
Kong Qingfei, Xiao Wen
wiley   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source